I like Leo's comment from his presentation that a 10 billion market cap isn't science fiction. That would be approximately 100 bucks/share. Replicate the results in human trials and Kevetrin will be as familiar to doctors as 5-fluorouracil and radiation therapy. Doctor's creed is "do no harm". If Kevetrin shows stat significant non geno-toxic results with efficacy, oncolgists will be jumping through hoops to incorporate Kevetrin as a solo treatment, or combo treatment. The potential is mind numbingly vast. You better believe CTIX will grow faster than most likely any stock that we have bought and held.